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SUMMARY
Molecular mechanisms of Trypanosoma cruzi (Tc)-induced Chagasic cardiomyopathy (CCM) are not well understood. The NO-cGMP-PKG1a pathway maintains cardiac homeostasis and inotropy and may be disturbed due to phosphodiesterase (PDE5)-mediated cGMP catabolism in CCM. To test this, C57BL/6 mice were infected with T. cruzi, and after the control of acute parasitemia (w45 days post-infection), given sildenafil (SIL) (1 mg/kg) treatment for 3 weeks that ended long before the chronic disease phase (w150 days post-infection). The PDE5 was increased and cGMP/PKG activity was decreased in chagasic myocardium. Transthoracic echocardiography revealed left ventricular (LV) systolic function, that is, stroke volume, cardiac output, and ejection fraction, was significantly decreased in chagasic mice. SIL treatment resulted in normal levels of PDE5 and cGMP/PKG activity and preserved the LV function. The cardioprotective effects of SIL were provided through inhibition of cardiac collagenosis and chronic inflammation that otherwise were pronounced in CCM. Further, SIL treatment restored the mitochondrial DNA-encoded gene expression, complex I-dependent (but not complex II-dependent) ADP-coupled respiration, and oxidant/antioxidant balance in chagasic myocardium. In vitro studies in cardiomyocytes verified that SIL conserved the redox metabolic state and cellular health via maintaining the antioxidant status that otherwise was compromised in response to T. cruzi infection. We conclude that SIL therapy Chronic progression of CCM is associated with persistent increase in circulatory and myocardial inflammatory and oxidative stress in human patients and experimental models (reviewed in [10] ). Although inflammatory stress is believed to be present in response to T. cruzi infection, we showed that mitochondrial inefficiency of respiratory chain was the major source of reactive oxygen species (ROS) in the heart (11) . Treatment of chagasic mice with a ROS scavenger (12) and mice genetically enhanced in their capacity to scavenge mitochondrial ROS (13) were better equipped in handling the oxidative and inflammatory stress, thus suggesting that ROS may signal chronic inflammation during CCM.
In the heart, nitric oxide (NO) and atrial natriuretic peptide signal the activation of guanylyl cyclase (GC) that produces cyclic guanosine monophosphate (cGMP) (14) . The cGMP binding activates cGMPdependent protein kinase (PKG). PKG phosphorylates serine and threonine residues on many cellular proteins and mediates the downstream effects in maintaining the force of contraction of cardiac myocytes (15) through regulating cytosolic free Ca 2þ level and sensitivity of muscle fibers to Ca 2þ (16) . Others have implied that cGMP/PKG regulate the activities of phosphodiesterases (PDEs) that hydrolyze cyclic nucleotides (17) . Of the 4 PDEs that are expressed in the heart and, in a feedback mechanism, that hydrolyze cyclic nucleotides, PDE5 is the only known cardiac phosphodiesterase that selectively hydrolyzes cGMP and negatively regulates cardiac inotropy (18) . An observation of PDE5 subcellular localization to myocyte z-bands (19) implies that it may exert its effects on cGMP/PKG signaling in a spatiotemporal manner and determine the functional outcomes in stressed heart. The NO-cGMP-PKG signaling may also occur in mitochondria and play a role in ischemic preconditioning and antioxidant cardioprotection (20) , though the exact mechanism remains to be identified. Wen et al.
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In this study, we aimed to determine whether treatment with PDE5 inhibitors would be beneficial in preserving cardiac hemodynamics in CCM. We also determined the molecular mechanism of cGMP/PKG in preventing pathological outcomes in CCM. We discuss the therapeutic role of PDE5 inhibitors in arresting the myocardial inflammation and mitochondrial oxidative stress that are hallmarks of chronic CCM. Wen et al.
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RESULTS
We used a well-established experimental model (26) to assess the role of PDE5 inhibition in control of Histological and molecular analysis of the myocardium showed the collagen deposits were increased by Mitochondrial activity of electron transport chain complexes is decreased in chagasic myocardium (28) .
To determine whether PDE5 contributes to mitochondrial dysfunction, we first performed quantitative evaluation of the mitochondrial DNA (mtDNA)-encoded gene expression in chagasic mice (AESIL).
These data showed a coordinated decline (27% to 58%) in the expression of mtDNA-encoded genes that are essential for the assembly of functional complex 1 (ND1 and ND4), complex III (CYTB), complex IV (COXIII), and complex V (ATP6) in cardiac biopsies of chagasic mice, when compared with that noted in normal mice ( Figure 3A , a-e) (all *p < 0.001 ANOVA/Tukey ).
In infected mice given SIL treatment, the ND1 mRNA level was preserved to normal level, and the expression of CYTB and ATP6 was improved by 49% to 50% in comparison to that noted in chagasic/ untreated mice ( Figure 3A 
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Sildenafil Efficacy in Chagas Disease metabolic state and cellular health were delivered via preserving the antioxidant status that otherwise was compromised in response to T. cruzi infection.
DISCUSSION
In this study, we tested the hypothesis that the PDE5 inhibitor SIL would be beneficial in controlling the chronic CCM caused by T. cruzi infection. Our proposal was on the basis of the literature that NO/cGMP maintain cardiac homeostasis and inotropy via PKG1a activation (31) , and PDE5 (catabolizes cGMP) is up regulated in hypertrophied heart (16, 32) . Mice infected with T. cruzi controlled the acute parasitemia within 45 days pi, but developed symptomatic CCC at >120 days pi (33) . We used this therapeutic window of indeterminate phase for short-term treatment with SIL for 21 days, beginning day 45 pi. Our data showed a powerful protective effect of SIL against cardiac collagenosis and LV dysfunction in chagasic heart. The beneficial effects of SIL were not delivered via its direct effect on parasite persistence that is suggested to be the major cause for the development of chronic cardiomyopathy (reviewed in [34, 35] Clearly, large randomized trials with careful documentation and analysis of effects of PDE5 inhibitors on micro and macro parameters of heart pathology and physiology will be required before the use of PDE5 inhibitors for management of heart disease can be clinically implemented.
CONCLUSIONS
In summary, our findings provide the first evidence that SIL has a powerful cardioprotective effect against TRANSLATIONAL OUTLOOK: Currently available PDE5 targeting drugs would potentially be useful for long-term health care of chagasic cardiomyopathy patients.
